The scientist’s investigation covers issues in Epilepsy, Internal medicine, Anticonvulsant, Endocrinology and Carbamazepine. Particularly relevant to Lamotrigine is his body of work in Epilepsy. His Internal medicine study combines topics in areas such as Physical therapy, Temporal lobe and Cardiology.
The concepts of his Anticonvulsant study are interwoven with issues in Hippocampal formation, Biochemistry, Astrocyte and Glutamic acid. His Endocrinology research is multidisciplinary, relying on both Valproic Acid and Levetiracetam. Leif Gjerstad works mostly in the field of Carbamazepine, limiting it down to topics relating to Randomized controlled trial and, in certain cases, Adverse effect, Tolerability, Cognition and Discontinuation, as a part of the same area of interest.
Leif Gjerstad spends much of his time researching Epilepsy, Internal medicine, Psychiatry, Pediatrics and Endocrinology. His Epilepsy research incorporates themes from Anesthesia and Randomized controlled trial. His Internal medicine research incorporates elements of Hippocampal sclerosis, Levetiracetam and Cardiology.
Many of his research projects under Psychiatry are closely connected to Norwegian with Norwegian, tying the diverse disciplines of science together. Leif Gjerstad interconnects Incidence, Quality of life, Stroke, Gynecology and Prospective cohort study in the investigation of issues within Pediatrics. His research on Endocrinology frequently connects to adjacent areas such as Valproic Acid.
His primary areas of investigation include Epilepsy, Psychiatry, Internal medicine, Pediatrics and White matter. His biological study spans a wide range of topics, including Young adult, Cause of death and Risk factor. His work deals with themes such as Hyperintensity, Electroencephalography and Cardiology, which intersect with Internal medicine.
His work carried out in the field of Pediatrics brings together such families of science as Recall and Verbal memory. His White matter research integrates issues from Partial volume, Diffusion MRI, Neuroscience and Synthetic data. Leif Gjerstad studied Lamotrigine and Carbamazepine that intersect with Phenytoin, Levetiracetam, Endocrinology, Anticonvulsant and Cognitive disorder.
His primary scientific interests are in Epilepsy, Diffusion MRI, White matter, Fractional anisotropy and Clinical psychology. Leif Gjerstad combines subjects such as Prospective cohort study and Pediatrics with his study of Epilepsy. The Diffusion MRI study combines topics in areas such as Cardiology, Internal medicine, Dementia, Memory clinic and Neuroscience.
His White matter study integrates concerns from other disciplines, such as Cognitive impairment and Audiology. His Fractional anisotropy study incorporates themes from Atrophy and Pathology. The study incorporates disciplines such as Psychosocial, Psychiatry, Socioeconomic status and Single parent in addition to Clinical psychology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Two different responses of hippocampal pyramidal cells to application of gamma-amino butyric acid.
P Andersen;R Dingledine;L Gjerstad;I A Langmoen.
The Journal of Physiology (1980)
Reduced inhibition during epileptiform activity in the in vitro hippocampal slice.
R Dingledine;L Gjerstad.
The Journal of Physiology (1980)
An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly
Erik Saetre;Emilio Perucca;Jouko Isojärvi;Leif Gjerstad.
Epilepsia (2007)
Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).
Morten Ingvar Lossius;Erik Hessen;Petter Mowinckel;Knut Stavem.
Epilepsia (2008)
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
Torbjörn Tomson;Torbjörn Tomson;Dina Battino;Erminio Bonizzoni;John Craig.
Lancet Neurology (2018)
Altered ovarian function and cardiovascular risk factors in valproate-treated women
Jouko I.T Isojärvi;Erik Taubøll;Arto J Pakarinen;Johan van Parys.
The American Journal of Medicine (2001)
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study
Dalia Kasperavičiūtė;Claudia B. Catarino;Erin L. Heinzen;Chantal Depondt.
Brain (2010)
New SCN5A mutation in a SUDEP victim with idiopathic epilepsy.
Dag Aurlien;Trond P. Leren;Erik Taubøll;Leif Gjerstad.
Seizure-european Journal of Epilepsy (2009)
Penicillin blocks hippocampal IPSPs, unmasking prolonged EPSPs.
Raymond Dingledine;Leif Gjerstad.
Brain Research (1979)
Poststroke epilepsy: occurrence and predictors--a long-term prospective controlled study (Akershus Stroke Study).
Morten I. Lossius;Ole M. Rønning;Geir D. Slapø;Petter Mowinckel.
Epilepsia (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Oslo University Hospital
Akershus University Hospital
University of Oslo
Haukeland University Hospital
Oslo University Hospital
University of Oslo
King's College London
University of Gothenburg
University of Oulu
University of Oslo
Stanford University
National University of Singapore
Technical University of Denmark
University of Bristol
Sun Yat-sen University
Princeton University
TU Dresden
University of Oregon
University of Manchester
University of Tennessee Health Science Center
University of Chicago
Stanford University
University of Bristol
Columbia University
Purdue University West Lafayette
Universität Hamburg